Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
34.72    0.48 (1.40%)
Bid:
34.80
Ask:
35.52
Spread: 0.72 (2.069%)
Market Cap: £555.18m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

CEO Succession

23 Feb 2023 07:00

RNS Number : 7736Q
Hays PLC
23 February 2023
 

This announcement contains inside information.

LEI code: 213800QC8AWD4BO8TH08

FOR IMMEDIATE RELEASE 23 February 2023

Hays plc

CEO Succession

Hays plc ("Hays" or the "Company"), the leading global specialist recruitment company, today announces that following discussions with Alistair Cox, Chief Executive Officer ("CEO"), it has been jointly agreed that it is an appropriate time to commence a process to identify Alistair's successor. Throughout this process Alistair will remain as CEO until a suitable candidate has been appointed and a handover has taken place. A thorough recruitment process, led by the Nomination Committee with the support of external consultants, is now underway, considering both internal and external candidates.

Alistair Cox, CEO, commented:

"It has been an honour and a privilege to lead Hays for over 15 years and I am extremely proud of, and grateful to, my colleagues for everything we have achieved together. While the process to appoint my successor is ongoing, it will be very much business as usual at Hays. Our strategy is delivering, we have a wealth of opportunities ahead and I remain fully focused on executing on our strategy as set out at our Investor Day in April 2022.

Andrew Martin, Chairman of Hays, commented:

"On behalf of the Board and everyone at Hays, I want to put on record our immense gratitude for Alistair's leadership. During Alistair's tenure, Hays has grown from a UK-focused business into a truly international leader in our industry. Alistair has set the stage for the next phase of the Group's development and the Board looks forward to working with him while we undertake a thorough process to identify his successor".

The person responsible for releasing this announcement is Doug Evans, General Counsel & Company Secretary.

For further information please contact:

Hays plc:

David Phillips Head of Investor Relations +44 (0) 333 010 7122

FGS Global:

Guy Lamming / Anjali Unnikrishnan at: hays@fgsglobal.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCNKBBBDBKBCBB
Date   Source Headline
4th Jun 20262:18 pmRNSDirector/PDMR Shareholding
1st Jun 202611:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSShare buyback programme
27th May 20269:14 amRNSHolding(s) in Company
19th May 20265:00 pmRNSDirector/PDMR Shareholding
18th May 20267:05 amRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSCEO Appointment
1st May 202610:00 amRNSTotal Voting Rights
29th Apr 20264:06 pmRNSDirector/PDMR Shareholding
28th Apr 20269:59 amRNSDirector/PDMR Shareholding
22nd Apr 20262:09 pmRNSHolding(s) in Company
22nd Apr 20262:06 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSThird Quarter Trading Statement
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 202611:00 amRNSTotal Voting Rights
27th Mar 20265:00 pmRNSHolding(s) in Company
27th Mar 20264:11 pmRNSDirector/PDMR Shareholding
25th Mar 202610:05 amRNSDirector/PDMR Shareholding
4th Mar 20261:24 pmRNSDirector/PDMR Shareholding
3rd Mar 20264:08 pmRNSDirector/PDMR Shareholding
2nd Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:00 amRNSTotal Voting Rights
27th Feb 20264:15 pmRNSHolding(s) in Company
27th Feb 20267:01 amRNSCEO departure and succession plan
27th Feb 20267:00 amRNSHalf-Year Report
2nd Feb 202611:00 amRNSTotal Voting Rights
14th Jan 20267:00 amRNSSecond Quarter Trading Statement
5th Jan 20267:00 amRNSCEO update
2nd Jan 202610:00 amRNSTotal Voting Rights
1st Dec 202511:00 amRNSTotal Voting Rights
21st Nov 20253:10 pmRNSDirector/PDMR Shareholding
19th Nov 20252:33 pmRNSResult of AGM
11th Nov 202512:00 pmRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSCEO Medical Leave
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 202510:00 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 202511:00 amRNSShare buyback programme
10th Oct 20257:00 amRNSFirst Quarter Trading Statement
6th Oct 202512:00 pmRNSPublication of Annual Report and Notice of AGM
3rd Oct 202511:09 amRNSDirector/PDMR Shareholding
1st Oct 202510:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.